{
  "title": "Why Are So Many Americans Hesitant To Get A COVID-19 Vaccine?",
  "description": "As trials continue for a coronavirus vaccine, some of the world's biggest drug companies have come together in an unusual way. This week, nine drugmakers released a <a href=\"https://www.npr.org/sections/coronavirus-live-updates/2020/09/08/910671322/9-drugmakers-sign-safety-pledge-in-race-to-develop-covid-19-vaccine\">joint statement pledging</a> to<strong> </strong>not submit a coronavirus vaccine to the Food and Drug Administration unless it's shown to be safe and effective in large clinical trials. <br/><br/>NPR's <a href=\"https://www.npr.org/people/825275572/sydney-lupkin\">Sydney Lupkin </a>reports that the statement comes as a <a href=\"https://www.npr.org/2020/09/08/910788743/9-companies-pledge-not-to-submit-coronavirus-vaccine-to-fda-until-its-proved-saf\">commitment to science,</a> at a time when some Americans have expressed concern that the trials are being rushed.<br/><br/>Part of this concern comes from those who feel politics are influencing the processes vaccines must go through. The Centers for Disease Control and Prevention have told states a potential vaccine may be ready for distribution as soon as late October — right before Election Day. But when speaking with NPR's Mary Louise Kelly, Dr. Moncef Slaoui, chief scientific adviser to Operation Warp Speed, said there is a <a href=\"https://www.npr.org/2020/09/03/909312697/operation-warp-speed-top-adviser-on-the-status-of-a-coronavirus-vaccine\">\"very low chance\"</a> a vaccine will be ready by then. <br/><br/>While some Americans are skeptical about a coronavirus vaccine, it doesn't seem like many of those people work on Wall Street. Each time a new vaccine trial phase is announced or a new scientific hurdle is cleared, drug company stock goes up. NPR's <a href=\"https://www.npr.org/people/349305392/tom-dreisbach\">Tom Dreisbach</a> reported that executives at one company<a href=\"https://www.npr.org/2020/09/04/908305074/bad-optics-or-something-more-moderna-executives-stock-sales-raise-concerns\"> took advantage of those rising stock prices</a>.<br/><br/><a href=\"https://www.npr.org/donations/support\">Find and support your local public radio station.</a><br/><br/>Email us at <a href=\"mailto:considerthis@npr.org\">considerthis@npr.org</a>",
  "pubDate": "Thu, 10 Sep 2020 17:30:54 -0400",
  "copyright": "Copyright 2020-2021 NPR - For Personal Use Only",
  "guid": "e50e5741-5d2c-4fdc-a9aa-f920351f288b",
  "link": "https://www.npr.org/2020/09/04/909669962/why-are-so-many-americans-hesitant-to-get-a-covid-19-vaccine",
  "itunes:title": "Why Are So Many Americans Hesitant To Get A COVID-19 Vaccine?",
  "itunes:author": "NPR",
  "itunes:summary": "Clinical trials are continuing as drug companies work toward creating a coronavirus vaccine. While hopes for a vaccine remain high, trust in the process to develop one is less so.",
  "itunes:subtitle": "Clinical trials are continuing as drug companies work toward creating a coronavirus vaccine. While hopes for a vaccine remain high, trust in the process to develop one is less so.",
  "itunes:image": "",
  "itunes:duration": 770,
  "itunes:explicit": "no",
  "itunes:episodeType": "full",
  "content:encoded": "As trials continue for a coronavirus vaccine, some of the world's biggest drug companies have come together in an unusual way. This week, nine drugmakers released a <a href=\"https://www.npr.org/sections/coronavirus-live-updates/2020/09/08/910671322/9-drugmakers-sign-safety-pledge-in-race-to-develop-covid-19-vaccine\">joint statement pledging</a> to<strong> </strong>not submit a coronavirus vaccine to the Food and Drug Administration unless it's shown to be safe and effective in large clinical trials. <br/><br/>NPR's <a href=\"https://www.npr.org/people/825275572/sydney-lupkin\">Sydney Lupkin </a>reports that the statement comes as a <a href=\"https://www.npr.org/2020/09/08/910788743/9-companies-pledge-not-to-submit-coronavirus-vaccine-to-fda-until-its-proved-saf\">commitment to science,</a> at a time when some Americans have expressed concern that the trials are being rushed.<br/><br/>Part of this concern comes from those who feel politics are influencing the processes vaccines must go through. The Centers for Disease Control and Prevention have told states a potential vaccine may be ready for distribution as soon as late October — right before Election Day. But when speaking with NPR's Mary Louise Kelly, Dr. Moncef Slaoui, chief scientific adviser to Operation Warp Speed, said there is a <a href=\"https://www.npr.org/2020/09/03/909312697/operation-warp-speed-top-adviser-on-the-status-of-a-coronavirus-vaccine\">\"very low chance\"</a> a vaccine will be ready by then. <br/><br/>While some Americans are skeptical about a coronavirus vaccine, it doesn't seem like many of those people work on Wall Street. Each time a new vaccine trial phase is announced or a new scientific hurdle is cleared, drug company stock goes up. NPR's <a href=\"https://www.npr.org/people/349305392/tom-dreisbach\">Tom Dreisbach</a> reported that executives at one company<a href=\"https://www.npr.org/2020/09/04/908305074/bad-optics-or-something-more-moderna-executives-stock-sales-raise-concerns\"> took advantage of those rising stock prices</a>.<br/><br/><a href=\"https://www.npr.org/donations/support\">Find and support your local public radio station.</a><br/><br/>Email us at <a href=\"mailto:considerthis@npr.org\">considerthis@npr.org</a>",
  "enclosure": ""
}